Adverse Events and Transitions of Care

This segment highlights the vital role of pharmacists and multidisciplinary teams in detecting, managing, and preventing toxicities. Common adverse effects—such as neutropenia, fatigue, and gastrointestinal symptoms—require proactive monitoring and timely dose adjustments. Early intervention allows patients to maintain therapy without compromising safety.

Panelists also explore how care coordination supports patient success during transitions between inpatient, outpatient, and community settings. Establishing standardized handoff processes and shared electronic records ensures continuity and reduces medication errors.

Ultimately, minimizing adverse events and optimizing communication among health care providers are key to maintaining adherence, preserving quality of life, and achieving the full therapeutic benefit of CDK4/6 inhibitors.